Master the complex pharmacology of anti-parasitic agents, including detailed mechanisms of action and clinical indications for treating protozoal and helminthic infections. This educational resource provides a clear breakdown of drug classes, from amebicides like metronidazole to a wide range of anthelmintics such as albendazole and praziquantel.
This resource offers an in-depth analysis of therapeutic strategies for major parasitic diseases, beginning with antiprotozoal agents for amebiasis. It details the use of metronidazole as the primary treatment for tissue infections and explores luminal amebicides, including iodoquinol and diloxanide furoate, for eradicating intestinal parasites. Furthermore, the guide covers specialized treatments for leishmaniasis, trypanosomiasis, and giardiasis, explaining the unique mechanisms of drugs such as sodium stibogluconate, suramin, and melarsoprol.
The second half of the material focuses on anthelmintics, categorizing drugs by their effectiveness against nematodes, trematodes, and cestodes. Students will learn about the benzimidazole family (albendazole, mebendazole) and their selective binding to parasite tubulin, as well as the actions of ivermectin, pyrantel pamoate, and praziquantel. The guide also emphasizes critical safety data, including contraindications for pregnancy and childhood use, and provides a thorough overview of adverse reactions such as the Mazzotti reaction.
